Adams Swann Arp, Choi Seul Ki, Eberth Jan M, Friedman Daniela B, Yip Mei Po, Tucker-Seeley Reginald D, Wigfall Lisa T, Hébert James R
1 Cancer Prevention and Control Program, Arnold School of Public Health, University of South Carolina , Columbia, South Carolina.
2 Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina , Columbia, South Carolina.
J Womens Health (Larchmt). 2015 Nov;24(11):916-23. doi: 10.1089/jwh.2014.5114. Epub 2015 Jul 24.
Mammography is the most effective method to detect breast cancer in its earliest stages, reducing the risk of breast cancer death. We investigated the relationship between accessibility of mammography services at Federally Qualified Health Centers (FQHCs) and mortality-to-incidence ratio (MIR) of breast cancer in each county in the United States.
County-level breast cancer mortality and incidence rates in 2006-2010 were used to estimate MIRs. We compared breast cancer MIRs based on the density and availability of FQHC delivery sites with or without mammography services both in the county and in the neighboring counties.
The relationship between breast cancer MIRs and access to mammography services at FQHCs differed by race and county of residence. Breast cancer MIRs were lower in counties with mammography facilities or FQHC delivery sites than in counties without a mammography facility or FQHC delivery site. This trend was stronger in urban counties (p=0.01) and among whites (p=0.008). Counties with a high density of mammography facilities had lower breast cancer MIRs than other counties, specifically in urban counties (p=0.01) and among whites (p=0.01). Breast cancer MIR for blacks was the lowest in counties having mammography facilities; and was highest in counties without a mammography facility within the county or the neighboring counties (p=0.03).
Mammography services provided at FQHCs may have a positive impact on breast cancer MIRs. Expansion of services provided at the FQHCs and placement of FQHCs in additional underserved areas might help to reduce cancer disparities in the United States.
乳腺钼靶检查是在乳腺癌最早期阶段进行检测的最有效方法,可降低乳腺癌死亡风险。我们调查了联邦合格医疗中心(FQHCs)的乳腺钼靶检查服务可及性与美国各县乳腺癌死亡率与发病率之比(MIR)之间的关系。
使用2006 - 2010年县级乳腺癌死亡率和发病率来估计MIRs。我们根据各县及相邻县内有无乳腺钼靶检查服务的FQHC提供点的密度和可及性,比较了乳腺癌MIRs。
乳腺癌MIRs与在FQHCs获得乳腺钼靶检查服务之间的关系因种族和居住县不同而有所差异。有乳腺钼靶检查设施或FQHC提供点的县的乳腺癌MIRs低于没有乳腺钼靶检查设施或FQHC提供点的县。这种趋势在城市县(p = 0.01)和白人中(p = 0.008)更为明显。乳腺钼靶检查设施密度高的县的乳腺癌MIRs低于其他县,特别是在城市县(p = 0.01)和白人中(p = 0.01)。黑人的乳腺癌MIR在有乳腺钼靶检查设施的县中最低;在本县或相邻县没有乳腺钼靶检查设施的县中最高(p = 0.03)。
FQHCs提供的乳腺钼靶检查服务可能对乳腺癌MIRs有积极影响。扩大FQHCs提供的服务范围以及在更多服务不足地区设立FQHCs可能有助于减少美国的癌症差异。